These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 10856736)

  • 21. Outpatient parenteral inotropic therapy for advanced heart failure.
    Young JB; Moen EK
    J Heart Lung Transplant; 2000 Aug; 19(8 Suppl):S49-57. PubMed ID: 11016488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing the effects of milrinone and olprinone in patients with congestive heart failure.
    Dobashi S; Watanabe I; Nakanishi R; Hisatake S; Kiuchi S; Kabuki T; Oka T; Fujii T; Ikeda T
    Heart Vessels; 2020 Jun; 35(6):776-785. PubMed ID: 31865433
    [TBL] [Abstract][Full Text] [Related]  

  • 23. IV milrinone for cardiac output increase and maintenance: comparison in nonhyperdynamic SIRS/sepsis and congestive heart failure.
    Heinz G; Geppert A; Delle Karth G; Reinelt P; Gschwandtner ME; Neunteufl T; Zauner C; Frossard M; Siostrzonek P
    Intensive Care Med; 1999 Jun; 25(6):620-4. PubMed ID: 10416916
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk stratification after hospitalization for decompensated heart failure.
    Felker GM; Leimberger JD; Califf RM; Cuffe MS; Massie BM; Adams KF; Gheorghiade M; O'Connor CM
    J Card Fail; 2004 Dec; 10(6):460-6. PubMed ID: 15599835
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous milrinone in treatment of advanced congestive heart failure.
    Zewail AM; Nawar M; Vrtovec B; Eastwood C; Kar MN; Delgado RM
    Tex Heart Inst J; 2003; 30(2):109-13. PubMed ID: 12809251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of phosphodiesterase inhibition with milrinone in combination with converting enzyme inhibitors in patients with heart failure. The Milrinone Multicenter Trials Investigators.
    Colucci WS; Sonnenblick EH; Adams KF; Berk M; Brozena SC; Cowley AJ; Grabicki JM; Kubo SA; LeJemtel T; Littler WA
    J Am Coll Cardiol; 1993 Oct; 22(4 Suppl A):113A-118A. PubMed ID: 8376682
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treating patients with severe heart failure.
    Eichhorn EJ
    Postgrad Med; 2002 Nov; 112(5 Suppl Unanswered):24-31. PubMed ID: 19667605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Omapatrilat for treatment of heart failure].
    Yamazaki T
    Nihon Rinsho; 2007 May; 65 Suppl 5():173-5. PubMed ID: 17571381
    [No Abstract]   [Full Text] [Related]  

  • 30. Comparison of dobutamine versus milrinone therapy in hospitalized patients awaiting cardiac transplantation: a prospective, randomized trial.
    Aranda JM; Schofield RS; Pauly DF; Cleeton TS; Walker TC; Monroe VS; Leach D; Lopez LM; Hill JA
    Am Heart J; 2003 Feb; 145(2):324-9. PubMed ID: 12595851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. National prescribing trends for heart failure medications in children.
    Moffett BS; Price JF
    Congenit Heart Dis; 2015; 10(1):78-85. PubMed ID: 24725766
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The changes of circulating tumor necrosis factor levels in patients with congestive heart failure influenced by therapy.
    Liu L; Zhao SP
    Int J Cardiol; 1999 Apr; 69(1):77-82. PubMed ID: 10362376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contemporary medical management of left ventricular dysfunction and congestive heart failure.
    Teo KK; Ignaszewski AP; Gutierrez R; Hill KL; Martin SL; Calhoun HP; Humen DP; Montague TJ
    Can J Cardiol; 1992; 8(6):611-9. PubMed ID: 1354569
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Omapatrilat--the story of Overture and Octave.
    Coats AJ
    Int J Cardiol; 2002 Nov; 86(1):1-4. PubMed ID: 12243845
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of inotropic support of the failing heart.
    Knight DH
    Vet Clin North Am Small Anim Pract; 1991 Sep; 21(5):879-904. PubMed ID: 1949498
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical trials update from the Heart Failure Society of America: EMOTE, HERB-CHF, BEST genetic sub-study and RHYTHM-ICD.
    Lalukota K; Cleland JG; Ingle L; Clark AL; Coletta AP
    Eur J Heart Fail; 2004 Dec; 6(7):953-5. PubMed ID: 15556058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Left ventricular assist device as destination for patients undergoing intravenous inotropic therapy: a subset analysis from REMATCH (Randomized Evaluation of Mechanical Assistance in Treatment of Chronic Heart Failure).
    Stevenson LW; Miller LW; Desvigne-Nickens P; Ascheim DD; Parides MK; Renlund DG; Oren RM; Krueger SK; Costanzo MR; Wann LS; Levitan RG; Mancini D;
    Circulation; 2004 Aug; 110(8):975-81. PubMed ID: 15313942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. When the heart runs out of heartbeats: treatment options for refractory end-stage heart failure.
    Ahmad T; Patel CB; Milano CA; Rogers JG
    Circulation; 2012 Jun; 125(23):2948-55. PubMed ID: 22689932
    [No Abstract]   [Full Text] [Related]  

  • 39. Comparison of dobutamine-based and milrinone-based therapy for advanced decompensated congestive heart failure: Hemodynamic efficacy, clinical outcome, and economic impact.
    Yamani MH; Haji SA; Starling RC; Kelly L; Albert N; Knack DL; Young JB
    Am Heart J; 2001 Dec; 142(6):998-1002. PubMed ID: 11717603
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of phosphodiesterase inhibitors on survival of patients with chronic congestive heart failure.
    Packer M
    Am J Cardiol; 1989 Jan; 63(2):41A-45A. PubMed ID: 2642629
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.